Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEE788 in recurrent glioblastoma multiforme
NCT00116376Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aee788 in glioblastoma multiforme (GBM), sponsored by Novartis. Started Jan 2004; status: completed.
02
Drugs
aee788
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00116376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116376.